The modulation of TRPM7 currents by nafamostat mesilate depends directly upon extracellular concentrations of divalent cations
2010

How Nafamostat Mesilate Affects TRPM7 Currents

Sample size: 11 publication 10 minutes Evidence: moderate

Author Information

Author(s): Chen Xuanmao, Numata Tomohiro, Li Minghua, Mori Yasuo, Orser Beverley A, Jackson Michael F, Xiong Zhi-Gang, MacDonald John F

Primary Institution: Department of Physiology, University of Toronto, Canada

Hypothesis

Nafamostat mesilate (NM) modulates TRPM7 currents based on extracellular concentrations of divalent cations.

Conclusion

Nafamostat mesilate can both block and activate TRPM7 currents depending on the concentration of extracellular divalent cations.

Supporting Evidence

  • Nafamostat mesilate blocks TRPM7 currents in HEK293T cells.
  • Lowering extracellular divalent cations enhances TRPM7 currents.
  • Nafamostat mesilate has an apparent affinity of 27 μM in cultured hippocampal neurons.
  • Nafamostat mesilate can paradoxically potentiate TRPM7 currents.
  • Nafamostat mesilate reduces intracellular Ca2+ influx in hippocampal neurons.

Takeaway

Nafamostat mesilate is a medicine that can change how certain channels in brain cells work, depending on the amount of calcium and magnesium around them.

Methodology

Electrophysiological recordings were made from HEK293T cells and cultured hippocampal neurons to assess TRPM7 currents.

Limitations

The study primarily focuses on in vitro models, which may not fully represent in vivo conditions.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1756-6606-3-38

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication